Intravenous Administration of Nicorandil Immediately Before Percutaneous Coronary Intervention Can Prevent Slow Coronary Flow Phenomenon - Intravenous Administration of Nicorandil Immediately Before Percutaneous Coronary Intervention Can Prevent Slow Coronary Flow Phenomenon

Description:

The goal of the trial was to evaluate treatment with nicorandil, a hybrid adenosine triphosphate-sensitive potassium channel (KATP) activator and vascular smooth muscle relaxant, in patients undergoing percutaneous coronary intervention (PCI).